The first good manufacturing practices facility located on a university campus in the United States opened this fall at the ...
ABSTRACT: Electrocochleography (ECoG) has been an important tool in the diagnosis of Meniere’s disease or endolymphatic hydrops. There are two methods employed, transtympanic and extratympanic. Many ...
The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
“Realized through collaboration between ECOG-ACRIN, NCI, and Caris Life Sciences, this public-private partnership represents a methodological, logistical, and collaborative integration of datasets ...
President Trump's comments about restarting weapons tests are not likely to lead to mushroom-cloud explosions over the New Mexico desert or seismic shaking underground in Nevada, according to the ...
Washington — President Trump directed the Pentagon on Wednesday to resume testing of nuclear weapons "on an equal basis" with other countries' tests, possibly ending a decades-long U.S. pause that ...
Trump ordered the Pentagon to restart nuclear testing for the first time since 1992, citing rival nations’ actions. Trump’s claim that the U.S. has the largest arsenal contradicts data showing Russia ...
President Donald Trump on Thursday vowed to begin testing US nuclear weapons “on an equal basis” with Russia and China, heralding a potentially major shift in decades of US policy at a time of growing ...
The president's announcement that the U.S. would resume tests leaves questions. President Donald Trump raised questions Wednesday night about a decades-old U.S. prohibition on testing its nuclear ...
President Trump explained the order by saying other, unnamed nations were testing their own nuclear weapons, even though no country has tested since 2017. By David E. Sanger and William J. Broad David ...
Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results